0001640455-22-000019.txt : 20220203
0001640455-22-000019.hdr.sgml : 20220203
20220203193841
ACCESSION NUMBER: 0001640455-22-000019
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cole Hugh M
CENTRAL INDEX KEY: 0001604646
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 22590404
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS, INC
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 454870634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_164393510740001.xml
FORM 4
X0306
4
2022-02-01
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0001604646
Cole Hugh M
C/O JOUNCE THERAPEUTICS, INC.
780 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
0
1
0
0
Chief Business Officer
Common Stock
2022-02-01
4
A
0
42500
0
A
106716
D
Stock Option (Right to Buy)
7.56
2022-02-01
4
A
0
85000
0
A
2032-02-01
Common Stock
85000.0
85000
D
The option will vest quarterly in 16 equal installments following January 1, 2022.
/s/ Caroline Gammill, Attorney-in-fact
2022-02-03